QP-Prostate®

Your advanced solution for prostate MRI based on Artificial Intelligence for cancer detection and diagnosis.

Book a demo

Discover QP-Prostate®
images_prostate_3d_3

Prostate cancer is the second most common  cancer in men, representing a significant public health concern. While MRI scans are essential for early detection, the growing demand has surpassed the availability of radiology experts, with diagnostic delays and inconsistencies in interpretation as direct consequences. Only a minority of the medical community consistently follows PI-RADS v2.1 guidelines.

QP-Prostate introduces enhanced diagnostic capabilities, streamlining radiologists’ workflows by automatically ensuring compliance with PI-RADS v2.1 guidelines, accurately segmenting the prostate gland, and efficiently identifying suspicious lesions. These advancements enable radiologists to provide faster and more accurate assessments, directly improving patient care.

 

Book a demo

Aggressive cancer detection and diagnosis

QP-Prostate is setting a new standard for accuracy, speed, and diagnostic precision. Its AI algorithm identifies and stratifies by likelihood intermediate and high-grade aggressive prostate cancer lesions, and provides a segmentation of the prostate. This allows Health Care Professionals to improve their diagnostic accuracy and fusion biopsy planning.

qp-prostate_seg_det_v6-3-2

 

Download the QP-Prostate Brochure

AI-QUAL™: Automated Prostate Image Quality Assessment

Quibim’s AI-QUAL™ automates the assessment of prostate MRI image quality based on the PI-QUALv2 guidelines. This tool streamlines workflows and supports diagnostic confidence.

 

Key benefits of AI-QUAL include:

  • Automated Quality Scoring: Eliminates manual checks, saving time and reducing subjectivity.
  • Standardized Reporting: Delivers consistent quality score based on PI-QUAL v2 guidelines.
  • Artifact Detection: Identifies key image-degrading factors such as rectal gas distortion and metal artifacts.
  • Diagnostic Confidence: Ensures radiologists work with the highest quality images.
  • Seamless Integration: Designed to fit effortlessly into existing radiology workflows.

 

aiqual5

Your AI solution for advanced prostate cancer detection

QP Prostate Sensitivity 90
Porst2
Pros3
qprostate_certifications2025
  • QP Prostate Sensitivity 90

    1. Unmatched clinical evidence

    Quibim is setting new benchmarks in diagnostic accuracy and elevating the standard in clinical practice. With a 10% increase in sensitivity, QP-Prostate AI tool increases expert radiologists’ detection rates by up to 90%*.
  • Porst2

    2. Optimizing specificity

    With Quibim’s dual-validation approach using both systematic and targeted biopsies, our algorithms are robustly validated against the most comprehensive ground truth data available in the industry.
  • Pros3

    3. Fully automated workflow

    Our workflow integrates seamlessly into existing systems, providing clinicians a streamlined, efficient diagnostic process that is unpaired in the industry.
  • qprostate_certifications2025

    4. Regulatory status

    Quibim meets international regulatory standards and is a pioneer in securing approvals across global markets. QP-Prostate has received, among others, CE marking, UKCA marking, and 510(k) clearance, setting us apart in the US market.

QP-Prostate: a set of enhanced diagnostic capabilities

  • Fully automated workflow

    All analysis outputs are directly sent back to the hospital PACS for their visualization without disrupting radiology workflows.

  • AI-Based automatic lesion detection

    Our AI algorithm, trained with pathology outcomes as ground truth, is designed to efficiently detect clinically significant prostate cancer lesions using biparametric inputs (T2w, DWI and ADC), outperforming competitors in detection rate and speed. These AI algorithms are intended to elevate radiologists’ diagnostic accuracy with automated detection of biopsy-proven, clinically significant prostate cancer lesions.

  • AI-QUAL™: Automated Prostate Image Quality Assessment

    AI-QUAL™ automates the assessment of prostate MRI image quality based on the PI-QUALv2 guidelines. This tool streamlines workflows and supports diagnostic confidence.

  • Precision in segmentation

    QP-Prostate’s AI algorithm automatically identifies the prostate anatomy and segments the full prostate gland with market-leading performance (88% DSC1), as well as the seminal vesicles, to assist in PSA density calculations. The results can be directly exported for fusion biopsy procedures.

 

Book a demo

How does it work?

Efficient workflow, increased confidence.
quibim-diagram-prostate

Clinical cases using QP-Prostate

CASE1_v1

Clinical Case 01.
65 yo biopsy patient with PSA: 5,1 ng/ml.

THE RADIOLOGIST DETECTS 3 LESIONS:
– L1 in the right anterolateral region of the medial gland in the transition zone. (PI-RADS 4).
– L2 in the right posterolateral region in the peripheral zone. (PI-RADS 3).
– L3 in the left posterolateral region of the apex in the peripheral zone. (PI-RADS 3).

QP-PROSTATE DETECTS 2 LESIONS:
– L1 Highly suspicious
– L2 No lesion.
– L3 Moderately suspicious.

TARGETED BIOPSY CONFIRMED 2 LESIONS:
– L1 Gleason score 4+3.
– L2  Benign Prostatic Tissue.
– L3 Gleason score  3+4.

CASE2_v2

Clinical Case 02.
74 yo biopsy patient with PSA: 15 ng/ml.

THE RADIOLOGIST DETECTS 1 LESION:
– L1  in the in the middle gland peripheral zone posteromedial/lateral area. (PI-RADS 4).

QP-PROSTATE DETECTS 1 LESION:
– L1 No lesion.
– L2 suspicious lesion.

TARGETED BIOPSY CONFIRMED 1 LESION:
– L1 Benign Prostatic Tissue.
– L2 Gleason score  4+3.

Clinical_Case_03

Clinical Case 03.
69 yo biopsy patient with PSA: 5 ng/ml.

THE RADIOLOGIST DETECTS 1 LESION:
– L1 (PI-RADS 3  DCE+, PIRADS 4).

QP-PROSTATE DETECTS 0 LESION:
– L1 No lesion.

TARGETED BIOPSY CONFIRMED 0 LESION:
– L1 Benign Prostatic Tissue.

Changing the narrative in prostate diagnosis thanks to maximum accuracy in prostate MRI interpretation

In short, QP-Prostate leverages advanced artificial intelligence image processing techniques to offer a state-of-the-art approach to prostate MRI interpretation. This image processing software is compatible with standard workstations and allows for the visualization and analysis of DICOM data by qualified professionals.

Developed by Quibim, QP-Prostate excels in automating the segmentation of critical prostate regions, including the transition zone, peripheral zone and seminal vesicles. By streamlining these complex processes, the software not only aids in the interpretation of prostate MRI images, but also enables more accurate diagnoses. This combination of sophisticated AI-based analysis and user-friendly implementation makes QP-Prostate an invaluable tool in the hands of healthcare professionals, ensuring better patient outcomes through more reliable and detailed assessments.

Interested in learning more?

References

  • Jimenez-Pastor A, et al.  Eur Radiol. 2023;33(7):5087-5096. 

  • Sánchez Iglesias Á, et al.  Cancers (Basel). 2023;15(16):4163. 

*Pilot study conducted in 2023 at Massachussets General Hospital.

Related articles

Interested on learning more about our products?

Book a demo

Interested on learning more about our products?

Book a demo
Quibim Website
Powered by  GDPR Cookie Compliance
Privacy Overview

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mainly used to make the site work as you expect it to. The information does not directly identify you but can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. However, blocking some types of cookies may impact your experience of the site. You can find more information, including a detailed cookie explanation, on our Cookie Policy.